Daniel Schneiderman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Schneiderman
Daniel Schneiderman is recorded as CFO at Pasithea Therapeutics Corp. (KTTA). Pasithea Therapeutics Corp. reported in an 8-K filed October 12, 2022 that Daniel Schneiderman was appointed Chief Financial Officer, effective October 11, 2022. The proxy statement of Pasithea Therapeutics Corp. reports total compensation of $895,187 for Daniel Schneiderman in fiscal 2025, including a base salary of $386,984. Disclosed compensation is on record for 5 fiscal years.
“Effective October 11, 2022, Daniel Schneiderman was appointed to serve as the Chief Financial Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Pasithea Therapeutics Corp.
Other people whose current roles at this company are on record from its filings.
- Dr. Tiago Reis Marques CEO, Board Member
- Prof. Lawrence Steinman Chairman
- Dr. Yassine Bendiabdallah COO
- Alfred J. Novak Board Member
- Alfred Novak Board Member
- Dr. Emer Leahy Board Member
- Emer Leahy Board Member
- Lawrence Steinman Board Member
- Simon Dumesnil Board Member
- Tiago Reis Marques Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Pasithea Therapeutics Corp. (KTTA) | Chief Financial Officer | $386,984 | $895,187 |
| 2024 | Pasithea Therapeutics Corp. (KTTA) | Chief Financial Officer | $330,000 | $430,223 |
| 2023 | Pasithea Therapeutics Corp. (KTTA) | Chief Financial Officer | $330,000 | $345,939 |
| 2022 | Pasithea Therapeutics Corp. (KTTA) | Chief Financial Officer | $135,205 | $367,203 |
| 2021 | Pasithea Therapeutics Corp. (KTTA) | Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.